Document is current

Article History

Received: 7 February 2026

Accepted: 10 March 2026

First Online: 1 April 2026

Declarations

:

: Dafna Yahav—collaborative retrospective study, Pfizer; funding for an investigator-initiated clinical study—Shionogi. Dafna Yahav is an Editorial Board member of Infectious Diseases and Therapy. Dafna Yahav was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Nadav Baharav, Michael Itzkovich, Eli Schwartz have no conflicts of interest to declare.

: This article is based on previously conducted studies; it does not contain new studies or participants. Ethical approval and informed consent were not required in accordance with the policies of our institution regarding meta-analysis of previously published studies.